Related Experiment Video
Updated: Jan 5, 2026

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze
Published on: October 29, 2019
Free Water in White Matter Differentiates MCI and AD From Control Subjects
Matthieu Dumont1, Maggie Roy1,2, Pierre-Marc Jodoin1,3
1Imeka Solutions, Inc., Sherbrooke, QC, Canada.
Abstract:
Recent evidence shows that neuroinflammation plays a role in many neurological diseases including mild cognitive impairment (MCI) and Alzheimer's disease (AD), and that free water (FW) modeling from clinically acquired diffusion MRI (DTI-like acquisitions) can be sensitive to this phenomenon. This FW index measures the fraction of the diffusion signal explained by isotropically unconstrained water, as estimated from a bi-tensor model. In this study, we developed a simple but powerful whole-brain FW measure designed for easy translation to clinical settings and potential use as a priori outcome measure in clinical trials. These simple FW measures use a "safe" white matter (WM) mask without gray matter (GM)/CSF partial volume contamination (WM safe) near ventricles and sulci. We investigated if FW inside the WM safe mask, including and excluding areas of white matter damage such as white matter hyperintensities (WMHs) as shown on T2 FLAIR, computed across the whole white matter could be indicative of diagnostic grouping along the AD continuum. After careful quality control, 81 cognitively normal controls (NC), 103 subjects with MCI and 42 with AD were selected from the ADNIGO and ADNI2 databases. We show that MCI and AD have significantly higher FW measures even after removing all partial volume contamination. We also show, for the first time, that when WMHs are removed from the masks, the significant results are maintained, which demonstrates that the FW measures are not just a byproduct of WMHs. Our new and simple FW measures can be used to increase our understanding of the role of inflammation-associated edema in AD and may aid in the differentiation of healthy subjects from MCI and AD patients.
Insights
Free water (FW) imaging detects neuroinflammation in mild cognitive impairment (MCI) and Alzheimer's disease (AD). This novel FW measure, excluding white matter damage, distinguishes healthy individuals from MCI and AD patients.
Area of Science:
- Neuroimaging
- Neurology
- Biomedical Engineering
Background:
- Neuroinflammation is implicated in neurological diseases like mild cognitive impairment (MCI) and Alzheimer's disease (AD).
- Free water (FW) imaging, derived from diffusion MRI, shows sensitivity to neuroinflammation.
Purpose of the Study:
- To develop a simple, clinically translatable whole-brain FW measure for neurological disease research.
- To investigate if FW measures in a "safe" white matter (WM) mask can differentiate diagnostic groups along the AD continuum.
Main Methods:
- A "safe" white matter (WM) mask was used, excluding gray matter/cerebrospinal fluid (CSF) partial volume effects.
- FW measures were computed across the whole WM, both including and excluding white matter hyperintensities (WMHs).
- Data from 81 normal controls (NC), 103 MCI, and 42 AD subjects from ADNI databases were analyzed.
Main Results:
- MCI and AD groups exhibited significantly higher FW measures compared to NC, even after removing partial volume contamination.
- These significant findings were maintained when white matter hyperintensities (WMHs) were excluded, indicating FW is not solely a byproduct of WMHs.
- The developed FW measures show potential for differentiating healthy individuals from those with MCI and AD.
Conclusions:
- The novel, simple FW measures are sensitive to changes along the AD continuum.
- These FW measures are not confounded by white matter hyperintensities.
- This approach may serve as a valuable tool for understanding inflammation-associated edema and aiding diagnosis in clinical trials.
More Related Videos
07:02Morris Water Maze Test for Learning and Memory Deficits in Alzheimer's Disease Model Mice
Published on: July 20, 2011
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....